Parthenolide: suggested drug for COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the 2019 novel coronavirus (2019-nCoV) that causes acute respiratory distress syndrome (ARDS) which is the main reason for patients mortality. One of the effective treatments to reduce the effects of this virus is parthenolide (PN). Par...
Guardado en:
Autores principales: | M. Nemati, F. Danesh Pouya, E. Roshani Asl, Y. Rami |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9315b89ca51547848e033744e355a25f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer
por: Jin X, et al.
Publicado: (2020) -
Ethical comments on COVID-19
por: O. I. Kubar
Publicado: (2020) -
The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients
por: Zainab Thanon Hasan, et al.
Publicado: (2022) -
The COVID-19 pandemic: a systematic review of the current evidence
por: R. Ghomi, et al.
Publicado: (2020) -
Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study
por: Chao Yu, et al.
Publicado: (2020)